Please login to the form below

Not currently logged in
Email:
Password:

Unlicensed Avastin

This page shows the latest Unlicensed Avastin news and features for those working in and with pharma, biotech and healthcare.

NHS wins legal fight with pharma over off-label Avastin

NHS wins legal fight with pharma over off-label Avastin

A group of NHS organisations have claimed a legal victory against Bayer and Novartis, which had sought to stop them using Avastin as a cheap, unlicensed substitute for their ophthalmology drugs. ... The case could not only open the door for more

Latest news

  • Bayer to challenge Avastin legal ruling Bayer to challenge Avastin legal ruling

    Bayer to challenge Avastin legal ruling. Both sides claim to be acting in patients' best interest. ... of rows over unlicensed use of Avastin in AMD.

  • Novartis 'in negotiations' over price of Lucentis in UK Novartis 'in negotiations' over price of Lucentis in UK

    However, at UK NHS prices Lucentis costs £741 per vial, compared to just £40 for Avastin. ... Novartis meanwhile has said there are serious safety concerns associated with the use of unlicensed Avastin in AMD, and has initiated legal proceedings

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

Marketing to healthcare professionals – what’s the key ingredient missing from most campaigns?
What do you think is the difference between a campaign developed to win a share-of-mind with consumers and a campaign designed to gain the attention of healthcare professionals?...
What everyone forgets about good organisational change in pharma
Natasha Cowan speaks to Daphne Chung, Head of Organisational Transformation, to learn how she ensures smooth organisational change that takes all stakeholders into account....
Live from Singapore: Oncology in APAC - Evaluating the opportunity for novel therapies
Live webinar: Tuesday 11th December 2018,16:00 SGT / 17:00 JST...

Infographics